Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Interferon Alpha
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Recipient : Ainos
Deal Size : Inapplicable
Deal Type : Inapplicable
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 17, 2010
Lead Product(s) : Interferon Alpha
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Recipient : Ainos
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
